New Leaf Venture Partners

Using software and services to capture, transmit and analyze data from connected medical devices in compliance with security, privacy and regulatory requirements

San Jose, CA

NLV-IV, NLV-III

Qlaris Bio

Novel treatments for ocular diseases

Boston, MA

NLV–IV

CuraSen Therapeutics, Inc.

Development of drugs for the treatment of CNS and neurodegenerative diseases

San Carolos, CA

NLV-IV / OPPORTUNITIES-II

ReViral

Clinical stage biopharmaceutical company focused on the development of antivirals for the treatment of (Respiratory Syncytial Virus ) RSV

Hertfordshire, United Kingdom

With the success of our entrepreneurs
our portfolio has

30 billion-dollar companies, 35 acquired companies,
and 54 companies taken public, with more to come

With the success of our entrepreneursour portfolio has

30 billion-dollar companies, 35 acquired companies,and 54 companies taken public, with more to come

With the success of our entrepreneurs
our portfolio has

30 billion-dollar companies, 35 acquired companies,
and 54 companies taken public, with more to come